MXPA01011047A - Secuencias genomicas de neisseria y metodos para su uso. - Google Patents
Secuencias genomicas de neisseria y metodos para su uso.Info
- Publication number
- MXPA01011047A MXPA01011047A MXPA01011047A MXPA01011047A MXPA01011047A MX PA01011047 A MXPA01011047 A MX PA01011047A MX PA01011047 A MXPA01011047 A MX PA01011047A MX PA01011047 A MXPA01011047 A MX PA01011047A MX PA01011047 A MXPA01011047 A MX PA01011047A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- genomic sequences
- neisseria
- sequences
- proteins
- Prior art date
Links
- 241000588653 Neisseria Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13206899P | 1999-04-30 | 1999-04-30 | |
| PCT/US1999/023573 WO2000022430A2 (en) | 1998-10-09 | 1999-10-08 | Neisseria genomic sequences and methods of their use |
| GB0004695A GB0004695D0 (en) | 2000-02-28 | 2000-02-28 | Protein expression |
| PCT/US2000/005928 WO2000066791A1 (en) | 1999-04-30 | 2000-03-08 | Neisseria genomic sequences and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01011047A true MXPA01011047A (es) | 2003-10-14 |
Family
ID=27255563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01011047A MXPA01011047A (es) | 1999-04-30 | 2000-03-08 | Secuencias genomicas de neisseria y metodos para su uso. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070219347A1 (es) |
| EP (2) | EP1605061A1 (es) |
| JP (1) | JP2003527079A (es) |
| CN (2) | CN1359426A (es) |
| AT (1) | ATE430207T1 (es) |
| AU (1) | AU780308B2 (es) |
| BR (1) | BR0010361A (es) |
| CA (1) | CA2371032A1 (es) |
| DE (1) | DE60042114D1 (es) |
| DK (1) | DK1185691T3 (es) |
| ES (1) | ES2323845T3 (es) |
| MX (1) | MXPA01011047A (es) |
| WO (1) | WO2000066791A1 (es) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1860192A1 (en) | 1996-09-17 | 2007-11-28 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for treating intracellular diseases |
| CA2650642A1 (en) | 1998-05-01 | 1999-11-11 | Chiron Corporation | Neisseria meningitidis antigens and compositions |
| CA2360667A1 (en) | 1999-01-22 | 2000-07-27 | Smithkline Beecham Biologicals S.A. | Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
| ES2337650T3 (es) | 1999-03-12 | 2010-04-28 | Glaxosmithkline Biologicals S.A. | Polipeptidos antigenicos de neisseria meningitidis polinucleotidos y anticuerpos protectores correspondientes. |
| AU4309600A (en) | 1999-04-30 | 2000-11-17 | Chiron S.R.L. | Conserved neisserial antigens |
| BR0010721A (pt) | 1999-05-19 | 2002-06-11 | Chiron Spa | Composições de neisserias combinadas |
| CA2389321A1 (en) | 1999-10-29 | 2001-05-03 | Chiron S.P.A. | Neisserial antigenic peptides |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| BR0107679A (pt) | 2000-01-17 | 2004-07-06 | Chiron Spa | Vacina de vesìcula de membrana externa (omv) compreendendo proteìnas de membrana externa do grupo sérico b de neisseria meningitidis |
| HUP0300696A3 (en) * | 2000-01-25 | 2004-10-28 | Univ Queensland Brisbane | Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| RU2304617C2 (ru) | 2000-02-28 | 2007-08-20 | Новартис Вэксинс Энд Диагностикс С.Р.Л. | Гибридная экспрессия белков neisseria |
| GB0011108D0 (en) * | 2000-05-08 | 2000-06-28 | Microscience Ltd | Virulence gene and protein and their use |
| EP1322328B1 (en) | 2000-07-27 | 2014-08-20 | Children's Hospital & Research Center at Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| GB0107219D0 (en) * | 2001-03-22 | 2001-05-16 | Microbiological Res Authority | Immunogenic commensal neisseria sequences |
| GB0108024D0 (en) * | 2001-03-30 | 2001-05-23 | Chiron Spa | Bacterial toxins |
| RU2355704C2 (ru) * | 2001-04-17 | 2009-05-20 | Новартис Вэксинс Энд Диагностикс, Инк | Моноклональное антитело, направленное против gna33 пептида, и его применение |
| US7534444B2 (en) * | 2001-04-17 | 2009-05-19 | Novattis Vaccines And Diagnostics, Inc. | Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| CA2452836C (en) | 2001-07-27 | 2012-11-27 | Chiron Srl | Meningococcus adhesins nada, app and orf 40 |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| CA2479879A1 (en) * | 2002-03-20 | 2003-10-02 | Emory University | Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| AU2003269864A1 (en) * | 2002-08-02 | 2004-02-25 | Glaxosmithkline Biologicals Sa | Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| US7785608B2 (en) | 2002-08-30 | 2010-08-31 | Wyeth Holdings Corporation | Immunogenic compositions for the prevention and treatment of meningococcal disease |
| SI2353608T1 (sl) | 2002-10-11 | 2020-12-31 | Glaxosmithkline Biologicals Sa | Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam |
| US7807802B2 (en) | 2002-11-12 | 2010-10-05 | Abbott Lab | Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| CN102302776B (zh) * | 2003-01-30 | 2014-06-18 | 诺华疫苗和诊断有限公司 | 抗多种脑膜炎球菌血清组的可注射性疫苗 |
| CU23237A1 (es) | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| PL2682126T3 (pl) | 2005-01-27 | 2017-07-31 | Children's Hospital & Research Center At Oakland | Szczepionki pęcherzykowe oparte na GNA1870 dla szerokiego spektrum ochrony przeciwko chorobom spowodowanym przez Neisseria meningitidis |
| JP2008529558A (ja) | 2005-02-18 | 2008-08-07 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | 髄膜炎／敗血症に関連する大腸菌由来のタンパク質および核酸 |
| NZ580974A (en) | 2005-02-18 | 2011-05-27 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic escherichia coli |
| AU2006220772A1 (en) * | 2005-03-04 | 2006-09-14 | Verenium Corporation | Nucleic acids and proteins and methods for making and using them |
| CU23578A1 (es) | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| CU23549A1 (es) * | 2005-12-29 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Composiciones farmacéuticas que contienen la proteína nma0939 |
| CN101479293A (zh) | 2006-06-29 | 2009-07-08 | 诺华有限公司 | 脑膜炎奈瑟球菌多肽 |
| EP2064230A2 (en) | 2006-08-16 | 2009-06-03 | Novartis AG | Immunogens from uropathogenic escherichia coli |
| CU23630A1 (es) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
| TW200902708A (en) | 2007-04-23 | 2009-01-16 | Wyeth Corp | Methods of protein production using anti-senescence compounds |
| GB0713880D0 (en) | 2007-07-17 | 2007-08-29 | Novartis Ag | Conjugate purification |
| CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
| CN104548082A (zh) | 2009-03-24 | 2015-04-29 | 诺华股份有限公司 | 为脑膜炎球菌因子h结合蛋白添加佐剂 |
| EP2429658B1 (fr) | 2009-05-14 | 2016-04-20 | Sanofi Pasteur | Procédé pour adjuver le lipopolysaccharide (LPS) des bactéries à gram-négatif |
| WO2011161653A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
| PL3831406T3 (pl) | 2010-08-23 | 2024-09-09 | Wyeth Llc | Stabilne preparaty antygenów rLP2086 Neisseria meningitidis |
| ES2759484T3 (es) | 2010-09-10 | 2020-05-11 | Glaxosmithkline Biologicals Sa | Meningococo que sobreexpresa NadA y/o NHBA y vesículas de la membrana externa derivadas del mismo |
| JP5976652B2 (ja) | 2010-09-10 | 2016-08-24 | ワイス・エルエルシー | 髄膜炎菌ｏｒｆ２０８６抗原の非脂質化変異体 |
| KR101763625B1 (ko) | 2012-03-09 | 2017-08-01 | 화이자 인코포레이티드 | 수막염균 조성물 및 이의 사용 방법 |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| AU2013276083B2 (en) | 2012-06-14 | 2018-04-05 | Institut Pasteur | Vaccines for serogroup X meningococcus |
| US10000545B2 (en) | 2012-07-27 | 2018-06-19 | Institut National De La Sante Et De La Recherche Medicale | CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endothelia |
| EP2964665B1 (en) | 2013-03-08 | 2018-08-01 | Pfizer Inc | Immunogenic fusion polypeptides |
| KR101905278B1 (ko) | 2013-09-08 | 2018-10-08 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| KR20190049940A (ko) | 2015-02-19 | 2019-05-09 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| WO2017137085A1 (en) | 2016-02-11 | 2017-08-17 | Sanofi Pasteur | Meningitidis vaccines comprising subtilinases |
| AU2018215585B2 (en) | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| WO2018206262A1 (en) * | 2017-05-10 | 2018-11-15 | Global Bioenergies | Improved methods for producing isobutene from 3-methylcrotonic acid |
| WO2019018744A1 (en) | 2017-07-21 | 2019-01-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | IMMUNOGENIC COMPOSITIONS OF NEISSERIA MENINGITIDIS |
| WO2020023717A2 (en) * | 2018-07-25 | 2020-01-30 | The Trustees Of Indiana University | Diagnostic assay for a strain of neisseria meningitidis |
| CN113136444B (zh) * | 2021-05-10 | 2024-04-19 | 临沂大学 | 医用食品中海氏肠球菌的微滴数字pcr检测方法 |
| CN116162140A (zh) * | 2022-07-19 | 2023-05-26 | 四川大学华西医院 | 一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用 |
| WO2025006737A1 (en) | 2023-06-30 | 2025-01-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine |
| WO2025077785A1 (zh) * | 2023-10-10 | 2025-04-17 | 康希诺生物股份公司 | 一种抗脑膜炎球菌的免疫组合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ238974A (en) * | 1990-07-19 | 1992-12-23 | Merck & Co Inc | Vaccine comprising the class ii major immuno-enhancing protein of the outer membrane of neisseria meningitidis covalently coupled to an antigen-specific composition of one such conjugate |
| CA2047043A1 (en) * | 1990-07-19 | 1992-01-20 | Allen I. Oliff | Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties |
| IE912559A1 (en) * | 1990-07-19 | 1992-01-29 | Merck & Co Inc | The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same |
| AU5426098A (en) * | 1996-10-24 | 1998-05-15 | Emory University | Invasion associated genes from (neisseria meningitidis) serogroup |
| NZ511540A (en) * | 1998-10-09 | 2004-05-28 | Chiron Corp | Neisseria genomic sequences and methods of their use |
-
2000
- 2000-03-08 CN CN00809820A patent/CN1359426A/zh active Pending
- 2000-03-08 ES ES00910392T patent/ES2323845T3/es not_active Expired - Lifetime
- 2000-03-08 CN CNA2007100037383A patent/CN101033467A/zh active Pending
- 2000-03-08 CA CA002371032A patent/CA2371032A1/en not_active Abandoned
- 2000-03-08 DE DE60042114T patent/DE60042114D1/de not_active Expired - Lifetime
- 2000-03-08 DK DK00910392T patent/DK1185691T3/da active
- 2000-03-08 WO PCT/US2000/005928 patent/WO2000066791A1/en active IP Right Grant
- 2000-03-08 AU AU32492/00A patent/AU780308B2/en not_active Ceased
- 2000-03-08 EP EP05075284A patent/EP1605061A1/en not_active Ceased
- 2000-03-08 BR BR0010361-6A patent/BR0010361A/pt not_active Application Discontinuation
- 2000-03-08 MX MXPA01011047A patent/MXPA01011047A/es active IP Right Grant
- 2000-03-08 EP EP00910392A patent/EP1185691B1/en not_active Expired - Lifetime
- 2000-03-08 JP JP2000615413A patent/JP2003527079A/ja active Pending
- 2000-03-08 AT AT00910392T patent/ATE430207T1/de active
-
2007
- 2007-02-26 US US11/711,740 patent/US20070219347A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070219347A1 (en) | 2007-09-20 |
| CN1359426A (zh) | 2002-07-17 |
| EP1185691B1 (en) | 2009-04-29 |
| CA2371032A1 (en) | 2000-11-09 |
| DK1185691T3 (da) | 2009-06-22 |
| EP1185691A1 (en) | 2002-03-13 |
| AU780308B2 (en) | 2005-03-17 |
| DE60042114D1 (de) | 2009-06-10 |
| EP1605061A1 (en) | 2005-12-14 |
| CN101033467A (zh) | 2007-09-12 |
| JP2003527079A (ja) | 2003-09-16 |
| ES2323845T3 (es) | 2009-07-27 |
| WO2000066791A1 (en) | 2000-11-09 |
| BR0010361A (pt) | 2003-06-10 |
| AU3249200A (en) | 2000-11-17 |
| ATE430207T1 (de) | 2009-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA01011047A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
| MXPA01003557A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
| MXPA00010722A (es) | Antigenos de neisseria meningitidis y composiciones que los contienen. | |
| SG152917A1 (en) | Neisseria meningitidis antigens | |
| CY1110880T1 (el) | Αντιγονα neisserial |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FG | Grant or registration | ||
| GB | Transfer or rights |